Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma.
Hiroaki KatagiNozomu TakataYuki AoiYongzhan ZhangEmily J RendlemanGavin T BlythFrank D EckerdtYusuke TomitaTakahiro SasakiAmanda M SaratsisAkihide KondoStewart GoldmanOren J BecherEdwin SmithLihua ZouAli ShilatifardRintaro HashizumePublished in: Neuro-oncology (2021)
SEC disruption by KL-1 increased therapeutic benefit in vitro and in vivo, supporting a potential therapeutic activity of KL-1 in H3K27M-mutant DIPG.